Pharmacogenomics

Papers
(The median citation count of Pharmacogenomics is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations39
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing27
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1227
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization25
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review25
Assessing patient understanding of pharmacogenomic test results: a qualitative study22
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting19
Genetics and response to treatment with metformin for type 2 diabetes18
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans16
Patient comprehension of preemptive pharmacogenomic results13
Rapid point of care testing: the next frontier in pharmacogenomics12
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications12
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level12
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations11
Contrasting ABCB1 Pharmacogenetics and Psychotropic Responses in Child and Adolescent Psychiatry: A case comparison11
Integrated in a Systems Pharmacology Approach, Pharmacogenetics holds the Promise for Personalized Medicine in Neonates11
Severe systemic Adverse Reactions to Ophthalmic Timolol in a CYP2D6 Homozygous *4 Allele Carrier: A Case Report10
Gene Polymorphisms Affect Postoperative Imatinib Plasma Levels and Edema in Adults With Gastrointestinal Stromal Tumor10
CYP2D6 genotyping in a Korean cohort: comparative analysis with Asian, Caucasian, and African populations10
Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study9
Association of NAT-2 Gene Polymorphisms Toward Lung Cancer Susceptibility and Prognosis in North Indian Patients Treated with Platinum-Based Chemotherapy9
Workforce readiness for pharmacogenomics and key elements for sustainment within the Veterans Health Administration9
CYP2D6 Gene Resequencing in the Malagasy, a Population at the Crossroads between Asia and Africa: A Pilot Study9
A Survey of Physician Opinions in Russia in the Field of Pharmacogenetics of Cardiovascular Disease9
Genetic polymorphisms and adverse reactions to antituberculosis therapy8
The Promise�of Digital Health in Healthcare Equity and Medication Adherence in the Disadvantaged Dementia Population8
Improving the Management of ALK-Rearranged Non-Small-Cell Lung Cancer Through a Mobile Application: A Physicians-Based Survey8
Cost–Effectiveness of HLA-B*58:01 Testing to Prevent Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis in Vietnam8
UGT1A1 Genotype-Guided Dosing of Irinotecan: Time to Prioritize Patient Safety8
EFfects of UGT1A , CYP2C9/19 and ABAT Polymorphisms on Plasma Concentration of Valproic Acid in Chinese Epi8
Multiple Genetic Mutations Increase the Risk of Thrombosis Associated With Clopidogrel After Percutaneous Coronary Intervention8
Pharmacogenomics and rare diseases: optimizing drug development and personalized therapeutics8
Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study7
Head-to-head Comparison of Various Antipsychotic Agents on Genome-Wide Methylation in Schizophrenia7
A critical review of RAF inhibitors in BRAF-mutated glioma treatment7
TPMT and NUDT15 genotyping, TPMT enzyme activity and metabolite determination for thiopurines therapy: a reference laboratory experience7
The cost–effectiveness of zolbetuximab in CLDN18.2-positive gastric or gastroesophageal junction adenocarcinoma7
Genetika+: Precision Medicine Solutions for Mental Health7
Effects of CYP3A4 and CYP2C9 Genotype on Systemic Anastrozole and Fulvestrant Concentrations in SWOG S02267
Accuracy and technical characteristics of CYP2C19 point of care tests: a systematic review6
Barriers and facilitators for implementing a pharmacogenetic passport: lessons learned from reusing sequencing data6
Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism6
Pharmacogenomic implications of the differential distribution of CYP3A5 metabolic phenotypes among Latin American populations6
Carbamazepine Cutaneous Adverse Reactions and HLA Gene Variation in the Chinese Population: A Systematic Review and Meta-Analysis6
DDX11-AS1 Modulates Dna Damage Repair to Enhance Paclitaxel Resistance of Lung Adenocarcinoma Cells6
SLCO1B1 and ABCB1 Variants Synergistically Influence the Atorvastatin Treatment Response in South Indian Coronary Artery Disease Patients6
The Festival of Genetics and Personalized Medicine6
Association between CYP3A4 , CYP3A5 and ABCB1 Genotype and Tacrolimus Treatment Outcomes Among Allogeneic H6
Donor-Derived Cell Free DNA as a Biomarker in Kidney Transplantation5
Knowledge and Attitudes of Incoming Pharmacy Students Toward Pharmacogenomics and Survey Reliability5
Patient Satisfaction With Return of Pharmacogenomic Results Utilizing a Patient Portal Message5
Pharmacogenomics: A Tool to Improve Medication Safety and Efficacy in Patients with Cystic Fibrosis5
Genetic risk factors for drug-induced long QT syndrome: findings from a large real-world case–control study5
Polymorphisms of Genes Related to Phase II Metabolism and Resistance to Clopidogrel5
Exploring the Potential Benefits of Pharmacogenomics in Chronic Respiratory Diseases5
Genetic polymorphisms of OPRM1 on the Efficacy and Safety of Anesthetic and Analgesic Agents: A Systematic Review5
XDH Genotypes Through Gene–Gene Interactions with NUDT15 Affect Azathioprine-Induced Leukopenia in Chinese Patients5
Estimated clinical utility of multi-gene pharmacogenetic testing in a retrospective cohort of gynecology patients5
Glutathione S -transferase Gene Polymorphism and Asthma: A Case–Control Study in a Pediatric Population5
Pharmacogenomics in Pediatric Medicine and Drug Development5
The Genetics of Drug-Induced Qt Prolongation: Evaluating the Evidence for Pharmacodynamic Variants5
DPYD Genotyping and Predicting Fluoropyrimidine Toxicity: Where do we Stand?5
Erratum5
Overview of the Year 2023 at Pharmacogenomics4
Relevance of NAT2 Genotype and Clinical Factors to Risk for Antituberculosis Drug-Induced Liver Injury4
Liquid biopsy: an essential tool for metastatic breast cancer’s follow-up4
Dosage Optimization of Clopidogrel Via a Precision Medicine Approach: The Way Forward4
Single-Nucleotide Polymorphisms in ABC Drug Transporters Alter Expression and Circulating Tenofovir in Healthy South African Women Exposed to Pre-Exposure Prophylaxis4
Variation in the ABC transporter genes and association with clinical outcomes in colorectal cancer: a brief review4
Pharmacogenetics of HIV Therapy: Challenges for Tailoring Treatment in Genetically Complex Populations4
The Revolution of Pharmaco-Omics: Ready to Open new Avenues in Materializing Precision Medicine?4
Posttransplantation diabetes mellitus (PTDM): pharmacological aspects and genetic predispositions4
The Frequency Of Rs2231142 in ABCG2 Among Native Hawaiian nd Pacific Islander Subgroups: Implications for Personalized Rosuvastatin Dosing4
Impact of ABCB1 gene polymorphism on clopidogrel plasma concentration and cardiovascular events in post-PCI patients4
Influence of CYP3A5 , IL-10 Polymorphisms and Metabolism Rate on Tacrolimus Exposure in Renal Post-Transplant Recipients4
The Importance of Phenoconversion when using the CYP2D6 Genotype in Clinical Practice4
Pharmacogenetics of Calcineurin inhibitors in kidney transplant recipients: the African gap. A narrative review4
Pharmacogenomic curriculum in Australian medical schools: a content analysis study4
Impact of CYP2C19 Gene Polymorphisms on Warfarin Dose Requirement: A Systematic Review and Meta-Analysis4
Pharmacogenomic Study of Anthracycline-Induced Cardiotoxicity in Mexican Pediatric Patients4
Bioinformatic Tools are Essential to Integrating Pharmacogenomics into Clinical Practice: Lessons from Neuropsychiatric Disorders4
Genome-Wide Association Study of Liver Enzyme Elevation in an Extended Cohort of Rheumatoid Arthritis Patients Starting Low-Dose Methotrexate4
Clinical Pharmacology and Pharmacogenomics for Implementation of Personalized Medicine4
KCNQ1 Variant rs163184 is a Potential Biomarker of Glycemic Response to Exenatide4
ATP Binding Cassette Transporters and Cancer: Revisiting Their Controversial Role3
Effects of the CYP2C19 LoF Allele on Major Adverse Cardiovascular Events Associated with Clopidogrel in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary3
Pharmacogenomics Implementation: “ A Little Less Conversation, a Little More Action, Please ”3
Targeting RET mutation in medullary thyroid cancer3
Evaluation of Pentamidine Tolerability and Efficacy Between CYP2C19 Phenotypes3
Healthcare Professionals’ Knowledge, Confidence and Perceptions of Pharmacogenomics in Primary Care and Pain Management3
Artificial intelligence, medications, pharmacogenomics, and ethics3
Pharmacogenetic Informed Care in Early Childhood: Options for Improving Access and Health Equity3
Implication of KDM6A in Bladder Cancer3
Use of a Consultation Service Following Pharmacogenetic Testing in Psychiatry3
Exploring precision medicine by utilizing individual genetic information for the management of Alzheimer’s disease3
lncRNA MALAT1 Regulates the Resistance of Breast Cancer Cells to Paclitaxel Via the miR-497-5p/ SHOC2 axis3
ABCB1 and OPRM1 Single-Nucleotide Polymorphisms Collectively Modulate Chronic Shoulder Pain and Dysfunction in South African Breast Cancer Survivors3
Pharmacogenomics education among professional societies: assessing practices and future needs3
Congruence Rates for Pharmacogenomic Noninterruptive Alerts3
Leveraging Clinical Decision Support to Reduce the Risk of Discordant Pharmacogenomics Results3
Influence of Polymorphisms in CYP2C9 , VKORC1 , MDR1 and APOE Genes on the W3
The pharmacogenetics of rosuvastatin and implications for treatment: a systematic review3
The Sixth European Society of Pharmacogenomics and Personalised Therapy Congress3
Genetic Variants of the Nuclear Factor Erythroid 2-Related Factor 2/Antioxidant Reaction Element Pathway on the Risk of Antituberculosis Drug-Induced Liver Injury: A Systematic Review3
Analysis of the Difference in SLCO1B1 and APOE Gene Polymorphisms Between Mongolian and Han Populations3
Genetic polymorphism associated with non-response to therapy in inflammatory bowel disease patients: a review3
Pharmacogenomic Variants Affecting Efficacy and Toxicity of Statins in a South Asian Population from Sri Lanka3
Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury3
Pharmacogenomic Prescribing Opportunities in Percutaneous Coronary Intervention and Bone Marrow Transplant Patients3
Psychiatric Level 1A Evidence Pharmacogenomics in a Brazilian Admixed Cohort and Global Populations3
Association of CYP2C19 , CYP3A4 and ABCC2 Polymorphisms and Voriconazole Plasma Concentrations in Uygur Ped3
Integrating Pharmacogenomic Testing Into Paired Germline and Somatic Genomic Testing in Patients with Cancer3
Pharmacogenetic Variants Influence Vitamin K Anticoagulant Dosing in Patients with Mechanical Prosthetic Heart Valves3
Pharmacoepigenomics: A Key Determinant in Resolving Epigenomic Parameters in Pathogenesis and Treatment Response in Complex Diseases3
Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients3
Antiplatelet Therapy Guided by CYP2C19 Point-of-Care Pharmacogenetics Plus Multidimensional Treatment Decisions2
Progression of Precision Statin Prescribing for Reduction of Statin-Associated Muscle Symptoms2
IL16 and Factor V Gene Variations are Associated with Asparaginase-Related Thrombosis in Childhood Acute Lymphoblastic Leukemia Patients2
Knowledge and perceptions of pharmacogenomics among pharmacists in Manitoba, Canada2
Evaluation of pharmacogenetic automated clinical decision support for clopidogrel2
Pharmacogenomics of Hydroxyurea Therapy and Fetal Hemoglobin Levels in Sickle Cell Anemia2
Application of Pharmacogenomics in Supportive Oncology: A Patient Journey2
Pharmacogenomics in Clinical Practice to Prevent Risperidone-Induced Hyperprolactinemia in Autism Spectrum Disorder2
Impact of the PEAR 1 Polymorphism on Clinical Outcomes in Chinese Patients Receiving Dual Antiplatelet Therapy After Percutaneous Coronary Interventio2
Whole-exome Sequencing Reveals Novel Candidate Single Nucleotide Variations for Preventing Adverse Effects of Levonorgestrel Implantation2
The genomic landscape of CYP2D6 variation in the Indian population2
TPMT Gene Polymorphisms (c.238G>C, c.460G>A and c.719A>G) in a Healthy Venezuelan Population2
Glaucoma diagnosis and treatment in the era of precision medicine2
Characterizing models for delivery of pharmacogenomic testing: a scoping review2
SLCO1B3 T334G Polymorphisms and Mycophenolate Mofetil-Related Adverse Reactions in Kidney Transplant Recipients2
Premarket Assessment of Molecular Alterations in Drug Targets: A Case Study of 2020 Drug Approvals2
Reinterpretation of pharmacogenomic phenotypes after combinatorial psychiatric testing2
Association of Polymorphisms in ARRB2 and Clinical Response to Methadone for Pain in Advanced Cancer2
Identification of Clinical and Pharmacogenetic Factors Influencing Metformin Response in Type 2 Diabetes Mellitus2
Pharmacogenomic markers associated with drug-induced QT prolongation: a systematic review2
Breast Cancer Pharmacogenetics: A Systematic Review2
Polymorphism of CYP3A4*18 is associated with anti-tuberculosis drug-induced hepatotoxicity2
Pharmacogenetic and Pharmacogenomic Treatment of Rheumatoid Arthritis: A Review of Pharmacogenomics Knowledge Base Scientific Evidence2
Pharmacogenetics of 6-Mercaptopurine in a Black Zimbabwean Cohort Treated for Acute Lymphoblastic Leukaemia2
Parental Understanding and Attitudes Following Pharmacogenomic Testing for Pediatric Neuropsychiatric Patients2
Pharmacogenetic Differentiation Across Latin America2
Effects of MDR1 and OPRM1 Genetic Polymorphisms on the Pharmacodynamics of Propofol–Remifentanil TIVA in Pediatrics2
Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro2
Pharmacogenetics Research in Brazil: A Systematic Review2
Pharmacogenetic Loci for Rosuvastatin are Associated with Intima-Media Thickness Change and Coronary Artery Disease Risk2
SALL4 upregulates brain-derived neurotrophic factor to mediate Hedgehog signaling to inhibit carboplatin sensitivity in colon adenocarcinoma2
Treatment of extended RAS/ BRAF wild-type metastatic colorectal cancer with anti-EGFR antibody combinations2
Comparing the clinical utility of pharmacogenomic genotyping and next generation sequencing in a military health system adult medicine clinic2
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse Events2
Warfarin Pharmacogenomics in African Populations: The Importance of Ethnicity-Based Algorithms2
An Interview with Dr Chiara Fabbri: Pharmacogenomics and Drug Repurposing for Treatment-Resistant Depression2
Considering Medication Exposure in Genomic Association Studies of Cognition in Psychotic Disorders2
0.22900009155273